<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Psychol Med</journal-id><journal-id journal-id-type="iso-abbrev">Psychol Med</journal-id><journal-id journal-id-type="publisher-id">PSM</journal-id><journal-title-group><journal-title>Psychological Medicine</journal-title></journal-title-group><issn pub-type="ppub">0033-2917</issn><issn pub-type="epub">1469-8978</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">28866988</article-id><article-id pub-id-type="pmc">5647677</article-id><article-id pub-id-type="doi">10.1017/S0033291717001234</article-id><article-id pub-id-type="pii">S0033291717001234</article-id><article-id pub-id-type="publisher-id">00123</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>A new generation computerised metacognitive cognitive remediation programme
for schizophrenia (CIRCuiTS): a randomised controlled trial</article-title><alt-title alt-title-type="left-running">C. Reeder et al.</alt-title><alt-title alt-title-type="right-running">A randomised controlled trial of
CIRCuiTS</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Reeder</surname><given-names>C.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref></contrib><contrib contrib-type="author"><name><surname>Huddy</surname><given-names>V.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Cella</surname><given-names>M.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Taylor</surname><given-names>R.</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Greenwood</surname><given-names>K.</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="aff" rid="aff4">4</xref></contrib><contrib contrib-type="author"><name><surname>Landau</surname><given-names>S.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="author-notes" rid="fns01">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Wykes</surname><given-names>T.</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="author-notes" rid="fns01">&#x02020;</xref></contrib></contrib-group><aff id="aff1"><label>1</label><institution>Institute of Psychiatry, Psychology and
Neuroscience (IoPPN), King's College London</institution>, <country>UK</country></aff><aff id="aff2"><label>2</label><institution>University College</institution>,
<addr-line>London</addr-line>, <country>UK</country></aff><aff id="aff3"><label>3</label><institution>Sussex Partnership NHS Foundation
Trust</institution>, <addr-line>Sussex</addr-line>, <country>UK</country></aff><aff id="aff4"><label>4</label><institution>School of Psychology, University of
Sussex</institution>, <addr-line>Falmer</addr-line>, <country>UK</country></aff><author-notes><corresp id="cor1"><label>*</label>Address for correspondence: Dr C. Reeder, Ph.D.,
<addr-line>Department of Psychology</addr-line>, <institution>PO77, IoPPN</institution>,
<addr-line>De Crespigny Park</addr-line>, <addr-line>Denmark Hill</addr-line>,
<addr-line>London, SE5 8AF</addr-line>, <country>UK</country>. (Email: <email>clare.reeder@kcl.ac.uk</email>)</corresp><fn id="fns01"><label>&#x02020;</label><p>Joint last authors.</p></fn></author-notes><pub-date pub-type="ppub"><month>11</month><year>2017</year></pub-date><pub-date pub-type="epub"><day>04</day><month>9</month><year>2017</year></pub-date><volume>47</volume><issue>15</issue><fpage>2720</fpage><lpage>2730</lpage><history><date date-type="received"><day>20</day><month>7</month><year>2016</year></date><date date-type="rev-recd"><day>06</day><month>4</month><year>2017</year></date><date date-type="accepted"><day>07</day><month>4</month><year>2017</year></date></history><permissions><copyright-statement>&#x000a9; Cambridge University Press 2017</copyright-statement><copyright-year>2017</copyright-year><copyright-holder>Cambridge University Press</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><!--CREATIVE COMMONS-->This is an Open Access article, distributed under the terms of the Creative
Commons Attribution licence (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits
unrestricted re-use, distribution, and reproduction in any medium, provided the original
work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0033291717001234a.pdf"/><abstract abstract-type="normal"><sec id="sec_a1"><title>Background</title><p>Cognitive remediation (CR) is a psychological therapy, which improves cognitive and
social functioning in people with schizophrenia. It is now being implemented within
routine clinical services and mechanisms of change are being explored. We designed a new
generation computerised CR programme, CIRCuiTS (Computerised Interactive Remediation of
Cognition &#x02013; a Training for Schizophrenia), to enhance strategic and metacognitive
processing, with an integrated focus on the transfer of cognitive skills to daily
living. This large trial tested its feasibility to be delivered in therapist-led and
independent sessions, and its efficacy for improved cognitive and social
functioning.</p></sec><sec id="sec_a2" sec-type="methods"><title>Methods</title><p>A two arm single blind randomised superiority trial comparing CIRCuiTS plus
treatment-as-usual (TAU) with TAU alone in 93 people with a diagnosis of schizophrenia.
Cognitive, social functioning and symptom outcomes were assessed at pre- and
post-therapy and 3 months later.</p></sec><sec id="sec_a3" sec-type="results"><title>Results</title><p>85% adhered to CIRCuiTS, completing a median of 28 sessions. There were significant
improvements in visual memory at post-treatment (<italic>p</italic> = 0.009) and
follow-up (<italic>p</italic> = 0.001), and a trend for improvements in executive
function at post-treatment (<italic>p</italic> = 0.056) in favour of the CIRCuiTS group.
Community function was also differentially and significantly improved in the CIRCuiTS
group at post-treatment (<italic>p</italic> = 0.003) but not follow-up, and was
specifically predicted by improved executive functions.</p></sec><sec id="sec_a4" sec-type="conclusion"><title>Conclusions</title><p>CIRCuiTS was beneficial for improving memory and social functioning. Improved executive
functioning emerges as a consistent predictor of functional gains and should be
considered an important CR target to achieve functional change. A larger-scale
effectiveness trial of CIRCuiTS is now indicated.</p></sec></abstract><kwd-group><title>Key words</title><kwd>Schizophrenia</kwd><kwd>psychosis</kwd><kwd>cognitive remediation</kwd><kwd>neuropsychology</kwd><kwd>metacognition</kwd><kwd>cognition</kwd><kwd>social functioning</kwd></kwd-group><counts><fig-count count="1"/><table-count count="3"/><ref-count count="40"/><page-count count="11"/></counts></article-meta></front><body><sec sec-type="intro" id="sec1"><title>Introduction</title><p>Cognitive dysfunction is a hallmark of a diagnosis of schizophrenia, a good predictor of
functional recovery (Green <italic>et al.</italic>
<xref rid="ref12" ref-type="bibr">2000</xref>) and consequently a valued treatment target
(Wykes &#x00026; Spaulding, <xref rid="ref40" ref-type="bibr">2011</xref>). Cognitive
remediation (CR) is &#x02018;a behavioural training-based intervention to improve cognitive
processes (e.g. attention, memory, executive functioning), with the general aim of durable
benefits on community functioning&#x02019; (CREW, <xref rid="ref6" ref-type="bibr">2012</xref>).
Meta-analytic results demonstrate beneficial effects on cognition and functioning
(Krabbendam &#x00026; Aleman, <xref rid="ref16" ref-type="bibr">2003</xref>; McGurk
<italic>et al.</italic>
<xref rid="ref19" ref-type="bibr">2007</xref>; Wykes <italic>et al.</italic>
<xref rid="ref36" ref-type="bibr">2011</xref>), although generalisation to functional
benefits are frequently restricted to strategy-based, rather than drill-and-practice, CR
approaches, delivered in the context of vocational rehabilitation (Wykes <italic>et al.</italic>
<xref rid="ref36" ref-type="bibr">2011</xref>; Drake <italic>et al.</italic>
<xref rid="ref8" ref-type="bibr">2014</xref>). There is consensus, with some supporting
evidence that cognitive improvements are likely to be maximised if the CR includes (i)
massed practice (i.e. highly repetitive practice taking place on several days a week for
prolonged periods), (ii) scaffolded learning facilitating high success rates, and (iii) a
focus on motivation (Wykes &#x00026; Reeder, <xref rid="ref37" ref-type="bibr">2005</xref>;
Wykes &#x00026; Spaulding, <xref rid="ref40" ref-type="bibr">2011</xref>; Vinogradov
<italic>et al.</italic>
<xref rid="ref32" ref-type="bibr">2012</xref>). CR programmes have generally not been
purpose-built and frequently do not use evidence-based principles to drive cognitive change,
or to generalise cognitive changes to functioning. The lack of an optimal, easy-to-deliver
CR programme is notable, given that CR is increasingly being adopted in governmental
guidelines (SIGN, <xref rid="ref28" ref-type="bibr">2013</xref>) and routine clinical
practice (New York State Office of Mental Health, <xref rid="ref30" ref-type="bibr">2010</xref>).</p><p>Our group has developed a new generation, computerised metacognitive CR programme, CIRCuiTS
[Computerised Interactive Remediation of Cognition &#x02013; a Training for Schizophrenia (Reeder
&#x00026; Wykes, <xref rid="ref25" ref-type="bibr">2010</xref>)], fit for widespread
clinical dissemination, which uses evidence-based cognitive training principles, and targets
functioning directly. Its focus on developing metacognition [i.e. thinking about thinking
(Flavell, <xref rid="ref10" ref-type="bibr">1979</xref>)] is underpinned by a model that
suggests that the transfer of cognitive skills to daily activities depends on metacognitive
knowledge and metacognitive regulation, or the ability to effectively understand and manage
one's own cognitive processes (Wykes &#x00026; Reeder, <xref rid="ref37" ref-type="bibr">2005</xref>). This entails a strategy-based approach, which is supported by studies
showing that changes in executive function (i.e. metacognitive regulation) better predict
functional change in schizophenia than changes in other cognitive processes such as memory
(Reeder <italic>et al.</italic>
<xref rid="ref24" ref-type="bibr">2006</xref>, <xref rid="ref22" ref-type="bibr">2014</xref>; Eack <italic>et al.</italic>
<xref rid="ref9" ref-type="bibr">2009</xref>; Wykes <italic>et al.</italic>
<xref rid="ref38" ref-type="bibr">2012</xref>).</p><p>CIRCuiTS was designed for people with a schizophrenia diagnosis and developed with service
user and therapist involvement. It is delivered by a therapist, supplemented by independent
sessions. It is highly acceptable to service users and clinicians (Reeder <italic>et al.</italic>
<xref rid="ref23" ref-type="bibr">2015</xref>). An independent randomised controlled trial
comparing CIRCuiTS plus Cognitive Behavioural Therapy for psychosis (CBTp) with social
contact plus CBTp (Drake <italic>et al.</italic>
<xref rid="ref8" ref-type="bibr">2014</xref>) showed that CIRCuiTS participants achieved the
same symptom improvements with significantly fewer CBTp sessions and signficantly greater
insight and executive improvements.</p><p>The current randomised controlled trial (RCT) compares CIRCuiTS plus treatment-as-usual
(TAU) with TAU alone in people with schizophrenia. Our objectives were to assess (i) the
feasibility of delivering CIRCuiTS with therapist-led sessions supplemented by independent
working; and (ii) the efficacy of CIRCuiTS for improved cognition and social
functioning.</p></sec><sec sec-type="methods" id="sec2"><title>Method</title><p>Ethical permission reference number 08/H0807/26.</p><sec id="sec2-1"><title>Design</title><p>A two arm randomised superiority trial comparing CIRCuiTS plus TAU with TAU alone.
Outcomes were measured at week 0 pre-randomisation (baseline), week 12 (post-treatment)
and week 26 (follow-up).</p></sec><sec id="sec2-2" sec-type="subjects"><title>Participants</title><p>Inclusion criteria were (i) DSM-IV diagnosis of schizophrenia or schizo-affective
disorder, (ii) at least 1 year's contact with mental health services, (iii) 17&#x02013;65 years,
and (iv) performance more than one <sc>s.d.</sc> below the normative mean in working
memory [digit span (Wechsler, <xref rid="ref34" ref-type="bibr">1993</xref>)] and/or
cognitive flexibility [Wisconsin Card Sorting Test (WCST) (Heaton <italic>et al.</italic>
<xref rid="ref14" ref-type="bibr">1993</xref>) or Hayling Sentence Completion Test
(Burgess &#x00026; Shallice, <xref rid="ref3" ref-type="bibr">1997</xref>)]. The protocol
criterion of poor social function was interpreted as not being in paid employment,
receiving financial benefits for disability, or not living independently, due to
difficulties in finding an informant for the pre-specified questionnaire. This criterion
was included since social functioning is a target of the intervention and a secondary
outcome. Therefore, participants needed to show room for improvement in this respect.
Exclusion criteria were (i) plans to change medication during the study, (ii) substance
dependence or (iii) evidence of an organic cause to cognitive difficulties.</p><p>Participants were recruited across the UK South London and Maudsley Mental Health
National Health Service (NHS) Foundation Trust. Following an explanation of the study,
written informed consent was obtained from all participants.</p></sec><sec id="sec2-3"><title>Interventions</title><sec id="sec2-3-1"><title>Treatment-as-usual</title><p>Routine psychiatric care provided within the UK National Health Service, which may have
taken place within community, inpatient or rehabilitation settings. In all settings,
this is likely to include individualised multi-disciplinary contacts such as medication
review and monitoring by a psychiatrist, regular meetings with a mental health nurse for
support, and less frequently, psychological or occupational therapy, residential support
with self-care, and attendance at day centres or rehabilitation programmes.</p></sec></sec><sec id="sec2-4"><title>CR programme [CIRCuiTS (Reeder &#x00026; Wykes, <xref rid="ref25" ref-type="bibr">2010</xref>; Reeder <italic>et al.</italic>
<xref rid="ref23" ref-type="bibr">2015</xref>)]</title><p>CIRCuiTS is a web-based computerised CR therapy, delivered by a therapist but
supplemented with independent sessions to facilitate massed practice. It targets
metacognition, particularly strategy use, in addition to providing massed practice of
basic cognitive functions. The therapist facilitates motivation, metacognitive and
strategy development and generalisation of learning by encouraging the participant to
learn about and regulate their cognitive performance and to transfer this learning to meet
real-world goals. Therapists provide additional scaffolding for CR tasks to ensure
consistent successful performance. Independent sessions involve carrying out cognitive
tasks allocated by the therapist to ensure scaffolded learning.</p><p>Real-world cognitive goals are set collaboratively, and then CIRCuiTS tasks are used to
identify cognitive strengths and difficulties and factors affecting cognitive performance.
The primary cognitive targets are attention, memory and executive functioning and
repetitive tasks gradually increase in difficulty in line with individual highly
successful performance. Participants develop a set of personalised strategies to improve
their cognitive performance, and achieve their goals.</p><p>The CR tasks are either &#x02018;abstract&#x02019; (neutral content, such as numbers, and designed to
target specific cognitive functions) or &#x02018;exercises&#x02019; (cognitively complex and ecologically
valid) associated with work, social situations, cooking, shopping and travelling. (Please
see the online Supplementary material 1 for some examples). Therapists encourage
participants to apply the skills learnt to daily life and to practice <italic>in
vivo,</italic> in order to achieve their real-world goals. Thus, functional outcomes are
directly targeted by the therapy.</p><sec id="sec2-4-1"><title>Rate of delivery</title><p>CIRCuiTS was offered at least three times a week (maximum 12 weeks), up to 40 sessions
lasting up to an hour. Where possible, according to participants&#x02019; ability and choice,
therapists encouraged them to carry out additional independent sessions (please see
online Supplementary material 1 for further information).</p></sec></sec><sec id="sec2-5"><title>Therapists and therapy fidelity</title><p>Therapists were supervised, trained graduate psychologists. A high degree of fidelity is
ensured using computerised delivery but audio-recordings of three sessions (from start,
middle and end of therapy) for all participants who consented to recordings
(<italic>n</italic>&#x000a0;=&#x000a0;28 sessions) were also rated using a modified CRT Fidelity Scale
(Stenmark, <xref rid="ref31" ref-type="bibr">2006</xref>) (see online Supplementary
materials 2).</p></sec><sec id="sec2-6"><title>Outcome measures</title><p>Participants were reimbursed &#x000a3;5 per hour for assessments.</p><sec id="sec2-6-1"><title>Baseline assessments</title><p><italic>Socio-demographic and clinical variables</italic> collated from participants,
case notes and mental health workers.</p><p><italic>Estimated premorbid full scale IQ:</italic> Wechsler Test of Adult Reading
(Wechsler, <xref rid="ref35" ref-type="bibr">2001</xref>).</p><p><italic>Estimated current IQ</italic> [<italic>pro-rated</italic> (Silverstein, <xref rid="ref29" ref-type="bibr">1982</xref>)]: Vocabulary and Block Design from the
Wechsler Adult Intelligence Scale &#x02013; Third Edition &#x02013; UK [WAIS-III-UK (Wechsler, <xref rid="ref34" ref-type="bibr">1993</xref>)].</p><p><italic>Symptoms:</italic> Positive and Negative Syndrome Scale (Kay <italic>et al.</italic>
<xref rid="ref15" ref-type="bibr">1987</xref>) (PANSS) (total score). A 30-item clinical
interview to assess symptom severity for schizophrenia, administered by trained graduate
psychologists achieving high inter-rater reliability to an expert trainer. Positive,
negative, disorganised, excited and depressed subscales were used (Wallwork <italic>et
al.</italic>
<xref rid="ref33" ref-type="bibr">2012</xref>).</p></sec><sec id="sec2-6-2"><title>Primary outcomes</title><p>The primary point of interest was 12 weeks (post-therapy).</p><p><italic>Verbal working memory:</italic> Digit Span [WAIS-III-UK (Wechsler, <xref rid="ref34" ref-type="bibr">1993</xref>)], a working memory task: total raw score
(high scores &#x02013; good performance).</p><p><italic>Visual memory:</italic> Rey Osterreith Complex Figure (ROCF) (Rey, <xref rid="ref26" ref-type="bibr">1941</xref>; Osterreith, <xref rid="ref21" ref-type="bibr">1944</xref>), a visual memory test: immediate recall raw score (high scores &#x02013; good
performance).</p><p><italic>Verbal executive function:</italic> Hayling Sentence Completion test (Burgess
&#x00026; Shallice, <xref rid="ref3" ref-type="bibr">1997</xref>), measuring response
inhibition: total scaled score (high scores &#x02013; good performance).</p><p><italic>Visual executive function:</italic> WCST (Heaton <italic>et al.</italic>
<xref rid="ref14" ref-type="bibr">1993</xref>), testing abstraction and cognitive
flexibility: percentage errors raw score (high scores &#x02013; poor performance).</p></sec><sec id="sec2-6-3"><title>Secondary outcomes</title><p><italic>Community functioning:</italic> Time Use Survey [UK 2000 Time Use Survey
(Short, <xref rid="ref27" ref-type="bibr">2006</xref>)]. A semi-structured interview
recording participants&#x02019; time use, selected to capture widely disparate clinically
meaningful increases in functional activity. Key outcome: total hours per week over the
past month spent in employment, education, voluntary work, voluntary and structured
leisure activities, housework and chores, childcare, sports and hobbies.</p><p><italic>Symptoms:</italic> PANSS: positive, negative and disorganised symptom subscales
(high scores &#x02013; high symptom levels).</p></sec></sec><sec id="sec2-7"><title>Sample size</title><p>Following the most recent meta-analysis (Wykes <italic>et al.</italic>
<xref rid="ref36" ref-type="bibr">2011</xref>), the planned sample size was revised to 44
per group allowing detection of an effect size of 0.6 or larger at post-treatment with 80%
power using an independent samples <italic>t</italic> test at the 5% significance level.
Assuming a drop out rate of 10%, 49 participants per group were needed.</p></sec><sec id="sec2-8"><title>Randomisation and blinding</title><p>Following the initial assessment, consecutive referrals of participants meeting inclusion
criteria were allocated (1:1) to CIRCuiTS plus TAU or TAU using an online system,
independently set up by the Clinical Trials Unit, KCL. A minimisation algorithm was used
to ensure balance in terms of the gender and age group (above and below 40 years)
stratifiers.</p><p>Graduate psychologists blind to group assignment conducted all assessments. All the
analyses not requiring group identification were carried out blind to allocation.</p></sec><sec id="sec2-9"><title>Statistical analyses</title><sec id="sec2-9-1"><title>Therapy feasibility analyses (conducted by CR)</title><p>These summarised therapy adherence (number and length of completed sessions, including
independent sessions) for all CIRCuiTS participants. We judged 20 sessions <italic>a
priori</italic> to constitute a minimum therapy course. Therapy completers and
non-completers and those who did and did not complete independent sessions were compared
on age, current IQ, five symptom dimensions and the primary cognitive outcomes at
baseline using <italic>t</italic> tests or Mann&#x02013;Whitney <italic>U</italic> tests.</p></sec><sec id="sec2-9-2"><title>Primary and secondary outcome group comparisons</title><p>Formal analyses were carried out on an intention-to-treat basis by SL to evaluate the
efficacy of CIRCuiTS in terms of primary and secondary outcomes at 12 and 26 weeks.</p><p>Linear mixed models fitted by maximum likelihood (ML) simultaneously modelled the 12
and 26 week data. The models were parameterised to provide separate group effect
estimates at 12 and 26 weeks (see <xref ref-type="table" rid="tab03">Table 3</xref>) and
effect estimates standardised by dividing by respective baseline <sc>s.d.</sc>s. Models
include (fixed) effects of time, trial arm and a group&#x000a0;&#x000d7;&#x000a0;time interaction. Models always
include randomisation stratifiers and baseline values of the variable under
investigation as a covariate to increase power. They further conditioned on variables
that were found to predict attrition to make more realistic assumptions regarding the
missing data mechanism. (The resulting ML estimates are valid under the missing at
random assumption). To detect such variables empirically a logistic regression was
conducted with the dependent variable &#x02018;missingness of the primary outcome variables at
26 weeks&#x02019;. This used a forward selection approach (inclusion threshold 10%) to test
whether any of: PANSS five factor scores, ethnic group, employment status, estimated
premorbid and current IQ, or baseline chlorpromazine equivalent, predicted missingness,
in addition to age and gender. PANSS excited scores and premorbid IQ were found to be
predictive and hence included as covariates in all analysis models. Finally linear mixed
models contained a randomly varying intercept at the level of the participant to account
for correlation between the two repeated measures.</p></sec><sec id="sec2-9-3"><title>Exploratory mechanism analyses</title><p>Therapy characteristics were correlated with change in each of the four primary
cognitive outcomes and community functioning over 12 weeks for CRT completers: (i) total
number of sessions completed, (ii) mean number of tasks completed per session, (iii)
mean number of strategies, rated with high usefulness, used per session, and (iv)
whether or not independent sessions were completed.</p><p>To explore whether change in any of the cognitive variables singly partially mediated
the effect of CIRCuiTS on the functioning outcome we followed a Baron&#x02013;Kenny approach
(Baron &#x00026; Kenny, <xref rid="ref1" ref-type="bibr">1986</xref>; MacKinnon
&#x00026; Valente, <xref rid="ref18" ref-type="bibr">2014</xref>). We adjusted mediator
and outcome models for covariates identified in the efficacy analyses.</p></sec></sec></sec><sec sec-type="results" id="sec3"><title>Results</title><p>In total 93 people were randomised between 24th May 2010 and 29th May 2012. The final
follow-up assessment was on 26th November 2012 (see <xref ref-type="fig" rid="fig01">Fig.
1</xref>). <fig id="fig01" orientation="portrait" position="float"><label>Fig. 1.</label><caption><p>Consort diagram.</p></caption><graphic xlink:href="S0033291717001234_fig1"/></fig></p><sec id="sec3-1"><title>Participant characteristics</title><p>Randomisation was successful in balancing the trial arms with regard to baseline
variables (see <xref ref-type="table" rid="tab01">Table 1</xref>). <table-wrap id="tab01" orientation="portrait" position="float"><label>Table 1.</label><caption><p>Participant characteristics</p></caption><alternatives><graphic xlink:href="S0033291717001234_tab1"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">Characteristic</th><th align="left" rowspan="1" colspan="1">Complete sample
(<italic>n</italic>&#x000a0;=&#x000a0;93) mean (<sc>s.d.</sc>)/frequency (%)</th><th align="left" rowspan="1" colspan="1">Group receiving CIRCuiTS
(<italic>n</italic>&#x000a0;=&#x000a0;46)</th><th align="left" rowspan="1" colspan="1">Group not receiving CIRCuiTS
(<italic>n</italic>&#x000a0;=&#x000a0;47)</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Age</td><td rowspan="1" colspan="1">38.3 years (10.4 years)</td><td rowspan="1" colspan="1">38.7 years (10.1 years)</td><td rowspan="1" colspan="1">37.9 years (10.9 years)</td></tr><tr><td rowspan="1" colspan="1">Gender</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Women</td><td rowspan="1" colspan="1">33 (35.5%)</td><td rowspan="1" colspan="1">14 (30.4%)</td><td rowspan="1" colspan="1">19 (40.4%)</td></tr><tr><td rowspan="1" colspan="1">Men</td><td rowspan="1" colspan="1">60 (64.5%)</td><td rowspan="1" colspan="1">32 (69.6%)</td><td rowspan="1" colspan="1">28 (59.6%)</td></tr><tr><td rowspan="1" colspan="1">Years in education</td><td rowspan="1" colspan="1">13.2 years (2.5 years)</td><td rowspan="1" colspan="1">13.5 years (2.6 years)</td><td rowspan="1" colspan="1">13.0 years (2.4 years)</td></tr><tr><td rowspan="1" colspan="1">Marital status</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Single</td><td rowspan="1" colspan="1">77 (82.8%)</td><td rowspan="1" colspan="1">39 (84.8%)</td><td rowspan="1" colspan="1">38 (80.9%)</td></tr><tr><td rowspan="1" colspan="1">Married</td><td rowspan="1" colspan="1">7 (7.5%)</td><td rowspan="1" colspan="1">3 (6.5%)</td><td rowspan="1" colspan="1">4 (8.5%)</td></tr><tr><td rowspan="1" colspan="1">Separated/divorced</td><td rowspan="1" colspan="1">9 (9.7%)</td><td rowspan="1" colspan="1">4 (8.7%)</td><td rowspan="1" colspan="1">5 (10.6%)</td></tr><tr><td rowspan="1" colspan="1">Estimated premorbid IQ</td><td rowspan="1" colspan="1">93.5 (10.8)</td><td rowspan="1" colspan="1">94.2 (10.5)</td><td rowspan="1" colspan="1">92.8 (11.2)</td></tr><tr><td rowspan="1" colspan="1">Current employment</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Paid or self employment</td><td rowspan="1" colspan="1">6 (6.5%)</td><td rowspan="1" colspan="1">3 (6.5%)</td><td rowspan="1" colspan="1">3 (6.4%)</td></tr><tr><td rowspan="1" colspan="1">Voluntary employment</td><td rowspan="1" colspan="1">16 (17.2%)</td><td rowspan="1" colspan="1">6 (13.0%)</td><td rowspan="1" colspan="1">10 (21.3%)</td></tr><tr><td rowspan="1" colspan="1">Unemployed</td><td rowspan="1" colspan="1">58 (62.3%)</td><td rowspan="1" colspan="1">29 (63.0%)</td><td rowspan="1" colspan="1">29 (61.7%)</td></tr><tr><td rowspan="1" colspan="1">Student</td><td rowspan="1" colspan="1">10 (10.8%)</td><td rowspan="1" colspan="1">6 (13.0%)</td><td rowspan="1" colspan="1">4 (8.5%)</td></tr><tr><td rowspan="1" colspan="1">Domestic responsibilities</td><td rowspan="1" colspan="1">2 (2.1%)</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">1 (2.1%)</td></tr><tr><td rowspan="1" colspan="1">Other</td><td rowspan="1" colspan="1">1 (1.1%)</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">0 (0.0%)</td></tr><tr><td rowspan="1" colspan="1">Current accommodation</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Independent accommodation</td><td rowspan="1" colspan="1">52 (55.9%)</td><td rowspan="1" colspan="1">23 (50.1%)</td><td rowspan="1" colspan="1">29 (61.7%)</td></tr><tr><td rowspan="1" colspan="1">Staffed accommodation</td><td rowspan="1" colspan="1">24 (25.8%)</td><td rowspan="1" colspan="1">14 (30.4%)</td><td rowspan="1" colspan="1">10 (21.2%)</td></tr><tr><td rowspan="1" colspan="1">Unstaffed group accommodation</td><td rowspan="1" colspan="1">3 (3.2%)</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">2 (4.3%)</td></tr><tr><td rowspan="1" colspan="1">Acute psychiatric ward</td><td rowspan="1" colspan="1">1 (1.1%)</td><td rowspan="1" colspan="1">0 (0.0%)</td><td rowspan="1" colspan="1">1 (2.1%)</td></tr><tr><td rowspan="1" colspan="1">Rehabiliation psychiatric ward</td><td rowspan="1" colspan="1">13 (14.0%)</td><td rowspan="1" colspan="1">8 (17.4%)</td><td rowspan="1" colspan="1">5 (10.6%)</td></tr><tr><td rowspan="1" colspan="1">Time since first psychiatric contact</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Less than 1 year</td><td rowspan="1" colspan="1">4 (4.3%)</td><td rowspan="1" colspan="1">1 (2.2%)</td><td rowspan="1" colspan="1">3 (6.4%)</td></tr><tr><td rowspan="1" colspan="1">1&#x02013;5 years</td><td rowspan="1" colspan="1">16 (17.2%)</td><td rowspan="1" colspan="1">8 (17.4%)</td><td rowspan="1" colspan="1">8 (17.0%)</td></tr><tr><td rowspan="1" colspan="1">5&#x02013;10 years</td><td rowspan="1" colspan="1">19 (20.4%)</td><td rowspan="1" colspan="1">4 (8.7%)</td><td rowspan="1" colspan="1">15 (31.9%)</td></tr><tr><td rowspan="1" colspan="1">More than 10 years</td><td rowspan="1" colspan="1">54 (58.1%)</td><td rowspan="1" colspan="1">33 (71.7%)</td><td rowspan="1" colspan="1">21 (44.7%)</td></tr><tr><td rowspan="1" colspan="1">Ethnicity</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">White</td><td rowspan="1" colspan="1">23 (24.7%)</td><td rowspan="1" colspan="1">13 (28.3%)</td><td rowspan="1" colspan="1">10 (21.3%)</td></tr><tr><td rowspan="1" colspan="1">Black</td><td rowspan="1" colspan="1">54 (58.1%)</td><td rowspan="1" colspan="1">25 (54.3%)</td><td rowspan="1" colspan="1">29 (61.7%)</td></tr><tr><td rowspan="1" colspan="1">Asian</td><td rowspan="1" colspan="1">6 (6.5%)</td><td rowspan="1" colspan="1">2 (4.3%)</td><td rowspan="1" colspan="1">4 (8.5%)</td></tr><tr><td rowspan="1" colspan="1">Mixed race</td><td rowspan="1" colspan="1">10 (10.8%)</td><td rowspan="1" colspan="1">6 (13.0%)</td><td rowspan="1" colspan="1">4 (8.5%)</td></tr><tr><td rowspan="1" colspan="1">PANSS</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Positive</td><td rowspan="1" colspan="1">8.5 (4.5)</td><td rowspan="1" colspan="1">8.3 (4.2)</td><td rowspan="1" colspan="1">8.7 (4.8)</td></tr><tr><td rowspan="1" colspan="1">Negative</td><td rowspan="1" colspan="1">10.8 (4.9)</td><td rowspan="1" colspan="1">11.2 (5.2)</td><td rowspan="1" colspan="1">10.5 (4.6)</td></tr><tr><td rowspan="1" colspan="1">Disorganised</td><td rowspan="1" colspan="1">8.0 (3.0)</td><td rowspan="1" colspan="1">8.1 (3.3)</td><td rowspan="1" colspan="1">8.0 (2.6)</td></tr><tr><td rowspan="1" colspan="1">Excited</td><td rowspan="1" colspan="1">5.3 (1.8)</td><td rowspan="1" colspan="1">5.4 (2.1)</td><td rowspan="1" colspan="1">5.1 (1.6)</td></tr><tr><td rowspan="1" colspan="1">Depressed</td><td rowspan="1" colspan="1">6.9 (3.2)</td><td rowspan="1" colspan="1">6.9 (3.3)</td><td rowspan="1" colspan="1">6.8 (3.1)</td></tr><tr><td rowspan="1" colspan="1">Medication</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Typical anti-psychotics</td><td rowspan="1" colspan="1">9 (9.7%)</td><td rowspan="1" colspan="1">4 (8.7%)</td><td rowspan="1" colspan="1">5 (10.6%)</td></tr><tr><td rowspan="1" colspan="1">Atypical anti-psychotics</td><td rowspan="1" colspan="1">82 (88.2%)</td><td rowspan="1" colspan="1">42 (91.3%)</td><td rowspan="1" colspan="1">43 (91.5%)</td></tr><tr><td rowspan="1" colspan="1">Risperidone</td><td rowspan="1" colspan="1">17 (18.3%)</td><td rowspan="1" colspan="1">9 (19.6%)</td><td rowspan="1" colspan="1">8 (17.0%)</td></tr><tr><td rowspan="1" colspan="1">Olanzapine</td><td rowspan="1" colspan="1">18 (19.4%)</td><td rowspan="1" colspan="1">9 (19.6%)</td><td rowspan="1" colspan="1">9 (19.1%)</td></tr><tr><td rowspan="1" colspan="1">Clozapine</td><td rowspan="1" colspan="1">30 (32.3%)</td><td rowspan="1" colspan="1">14 (30.4%)</td><td rowspan="1" colspan="1">16 (34.0%)</td></tr><tr><td rowspan="1" colspan="1">Chlorpromazine equivalent dosage</td><td rowspan="1" colspan="1" align="left">Median 333.3&#x000a0;mg (0&#x02013;1920.0&#x000a0;mg)</td><td rowspan="1" colspan="1" align="left">Median 326.6&#x000a0;mg (0&#x02013;1920.0&#x000a0;mg)</td><td rowspan="1" colspan="1" align="left">Median 377.5&#x000a0;mg (43.8&#x02013;1800.0&#x000a0;mg)</td></tr></tbody></table></alternatives></table-wrap></p><p>Only four participants were completely lost to follow-up (i.e. 4.3% at both 12 and 26
week assessment time points, <xref ref-type="fig" rid="fig01">Fig. 1</xref>). 17
participants had a missing value for at least one of the four primary outcome variables at
26 weeks (18.3%).</p></sec><sec id="sec3-2"><title>CIRCuiTS feasibility</title><p>Of the seven (15%) non-completers, six completed only one or two sessions, and one
completed 16 sessions. For all CIRCuiTS participants, the median number of sessions
completed was 25.5 (range 1&#x02013;41). Amongst completers, the median was 27.5 (20&#x02013;41), the mean
session length was 45.5&#x000a0;min (<sc>s.d.</sc> 10.2), a mean of 4.8 (<sc>s.d.</sc> 1.6) tasks
per session were completed and a mean of 7.1 (<sc>s.d.</sc> 4.2) useful strategies used
per session.</p><p>Nine people (20%) completed at least one independent session (median 6, 1&#x02013;10).
Participants who completed independent sessions completed a similar number of sessions
overall (median 27.5, 20&#x02013;41) to those who did not complete independent sessions (median
27.0, 20&#x02013;40). The only significant difference (<italic>t</italic>&#x000a0;=&#x000a0;2.8, df&#x000a0;=&#x000a0;39.6,
<italic>p</italic>&#x000a0;=&#x000a0;0.007), with little clinical importance, between those completing
independent sessions and those who did not, was on the PANSS excited score: independent
sessions mean&#x000a0;=&#x000a0;5.68, <sc>s.d.</sc>&#x000a0;=&#x000a0;2.2; no independent sessions mean&#x000a0;=&#x000a0;4.44,
<sc>s.d.</sc>&#x000a0;=&#x000a0;0.73).</p><p>Five therapists conducted the CRT with three seeing fewer than 10 patients. The majority
of rated sessions (18 sessions &#x02013; 64.2%) were scored 7/7 on the modified CRT Fidelity Scale
and the lowest score (only three sessions &#x02013; 10.7%) was 5/7.</p></sec><sec id="sec3-3"><title>Does CIRCuiTS lead to improved cognitive and functioning outcomes?</title><p>Table S1 (please see online Supplementary material 3) summarises observed primary and
secondary outcomes.</p><p><xref ref-type="table" rid="tab02">Table 2</xref> shows the results of the formal
statistical analyses. Since we had four primary outcomes, the significance level was
adjusted (<italic>&#x003b1;</italic>&#x000a0;=&#x000a0;0.05/4&#x000a0;=&#x000a0;0.0125). We found significant improvements for
immediate visual memory at post-treatment (<italic>p</italic>&#x000a0;=&#x000a0;0.009) and at follow-up
(<italic>p</italic>&#x000a0;=&#x000a0;0.001), and a trend for improvement in non-verbal executive
functioning at post-treatment (<italic>p</italic>&#x000a0;=&#x000a0;0.056), in favour of CIRCuiTS. The
secondary outcome analyses demonstrated that CIRCuiTS participants spent significantly
more time in structured activities at post-treatment (<italic>p</italic>&#x000a0;=&#x000a0;0.003). There
was also some evidence (<italic>p</italic>&#x000a0;=&#x000a0;0.049) that PANSS positive symptoms were
lower in the CIRCuiTS arm at post-treatment. <table-wrap id="tab02" orientation="portrait" position="float"><label>Table 2.</label><caption><p>Estimated treatment group effects at 12 and 26 weeks post randomisation</p></caption><alternatives><graphic xlink:href="S0033291717001234_tab2"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><thead><tr><th rowspan="1" colspan="1"/><th colspan="2" align="left" rowspan="1">12 weeks</th><th colspan="2" align="left" rowspan="1">26 weeks</th></tr><tr><th align="left" rowspan="1" colspan="1">Outcome</th><th align="left" rowspan="1" colspan="1"><italic>z</italic>-statistic
(<italic>p</italic> value)</th><th align="left" rowspan="1" colspan="1">Estimated difference (TAU-CR) [95% CI]
Stand. effect size</th><th align="left" rowspan="1" colspan="1"><italic>z</italic>-statistic
(<italic>p</italic> value)</th><th align="left" rowspan="1" colspan="1">Estimated difference (TAU-CR) [95% CI]
Stand. effect size</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">
<italic>Primary outcomes</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Verbal working memory (Digit span)</td><td rowspan="1" colspan="1">&#x02212;1.19 (<italic>p</italic>&#x000a0;=&#x000a0;0.24)</td><td rowspan="1" colspan="1">&#x02212;0.564 [&#x02212;1.494 to 0.366] ES&#x000a0;=&#x000a0;&#x02212;0.16</td><td rowspan="1" colspan="1">&#x02212;0.99 (<italic>p</italic>&#x000a0;=&#x000a0;0.32)</td><td rowspan="1" colspan="1">&#x02212;0.474 [&#x02212;1.417 to 0.464] ES&#x000a0;=&#x000a0;&#x02212;0.13</td></tr><tr><td rowspan="1" colspan="1">Visual memory (ROCF)</td><td rowspan="1" colspan="1">&#x02212;2.63 (<italic>p</italic>&#x000a0;=&#x000a0;0.009)</td><td rowspan="1" colspan="1">&#x02212;2.403 [&#x02212;4.194 to &#x02212;0.611] ES&#x000a0;=&#x000a0;&#x02212;0.35</td><td rowspan="1" colspan="1">&#x02212;3.46 (<italic>p</italic>&#x000a0;=&#x000a0;0.001)</td><td rowspan="1" colspan="1">&#x02212;3.166 [&#x02212;4.957 to &#x02212;1.374] ES&#x000a0;=&#x000a0;&#x02212;0.46</td></tr><tr><td rowspan="1" colspan="1">Verbal executive function (Hayling)</td><td rowspan="1" colspan="1">&#x02212;0.65 (<italic>p</italic>&#x000a0;=&#x000a0;0.52)</td><td rowspan="1" colspan="1">&#x02212;0.421 [&#x02212;1.699 to 0.857] ES&#x000a0;=&#x000a0;&#x02212;0.09</td><td rowspan="1" colspan="1">&#x02212;0.83 (<italic>p</italic>&#x000a0;=&#x000a0;0.41)</td><td rowspan="1" colspan="1">&#x02212;0.545 [&#x02212;1.839 to 0.749] ES&#x000a0;=&#x000a0;&#x02212;0.12</td></tr><tr><td rowspan="1" colspan="1">Visual executive function (WCST)</td><td rowspan="1" colspan="1">1.91 (<italic>p</italic>&#x000a0;=&#x000a0;0.056)</td><td rowspan="1" colspan="1">6.531 [&#x02212;0.176 to 13.237] ES&#x000a0;=&#x000a0;0.36</td><td rowspan="1" colspan="1">1.66 (<italic>p</italic>&#x000a0;=&#x000a0;0.098)</td><td rowspan="1" colspan="1">5.713 [&#x02212;1.046 to 12.473] ES&#x000a0;=&#x000a0;0.32</td></tr><tr><td rowspan="1" colspan="1">
<italic>Secondary outcomes</italic>
</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Time spend in structured activities<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref></td><td rowspan="1" colspan="1">&#x02212;3.01 (<italic>p</italic>&#x000a0;=&#x000a0;0.003)</td><td rowspan="1" colspan="1">0.622<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.457&#x02013;0.847]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;&#x02212;0.55</td><td rowspan="1" colspan="1">&#x02212;0.42 (<italic>p</italic>&#x000a0;=&#x000a0;0.67)</td><td rowspan="1" colspan="1">0.936<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.687&#x02013;1.276]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;&#x02212;0.08</td></tr><tr><td rowspan="1" colspan="1">Positive symptoms<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> (PANSS)</td><td rowspan="1" colspan="1">1.97 (<italic>p</italic>&#x000a0;=&#x000a0;0.049)</td><td rowspan="1" colspan="1">1.129<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [1.001&#x02013;1.275]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;0.24</td><td rowspan="1" colspan="1">0.26 (<italic>p</italic>&#x000a0;=&#x000a0;0.80)</td><td rowspan="1" colspan="1">1.016<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.899&#x02013;1.149]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;0.03</td></tr><tr><td rowspan="1" colspan="1">Negative symptoms<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> (PANSS)</td><td rowspan="1" colspan="1">&#x02212;0.21 (<italic>p</italic>&#x000a0;=&#x000a0;0.83)</td><td rowspan="1" colspan="1">0.986<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.870&#x02013;1.119]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;&#x02212;0.03</td><td rowspan="1" colspan="1">0.47 (<italic>p</italic>&#x000a0;=&#x000a0;0.63)</td><td rowspan="1" colspan="1">1.031<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.908&#x02013;1.172]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;0.08</td></tr><tr><td rowspan="1" colspan="1">Disorganised symptoms<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> (PANSS)</td><td rowspan="1" colspan="1">1.28 (<italic>p</italic>&#x000a0;=&#x000a0;0.20)</td><td rowspan="1" colspan="1">1.073<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.964&#x02013;1.194]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;0.20</td><td rowspan="1" colspan="1">1.81 (<italic>p</italic>&#x000a0;=&#x000a0;0.07)</td><td rowspan="1" colspan="1">1.106<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> [0.992&#x02013;1.233]<xref ref-type="table-fn" rid="tfn2_1">
<sup>a</sup>
</xref> ES&#x000a0;=&#x000a0;0.28</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tfn2_1"><label>a</label><p>Outcome was analysed on the ln-scale due to positive skewness. Unstandardised
effect estimates represent multiplicative (factor) effects and need to be compared
with the factor value &#x02018;1&#x02019; (=no group effect).</p></fn></table-wrap-foot></table-wrap></p></sec><sec id="sec3-4"><title>Are aspects of therapy associated with cognitive and functional outcomes?</title><p>More completed sessions were associated with greater non-verbal executive improvement
(<italic>r</italic>&#x000a0;=&#x000a0;&#x02212;0.31) at 12 weeks and a larger benefit for structured activity
(<italic>r</italic>&#x000a0;=&#x000a0;0.22). Improvement in visual memory was associated with more tasks
completed and a higher number of useful strategies (<italic>r</italic>&#x000a0;=&#x000a0;0.39 and
<italic>r</italic>&#x000a0;=&#x000a0;0.24 respectively). Completion of independent sessions was not
associated with any outcome.</p></sec><sec id="sec3-5"><title>Does cognition mediate the CR effect on functioning?</title><p>The exploratory mediation analyses are summarised in <xref ref-type="table" rid="tab03">Table 3</xref>. Change in only one of the four primary cognitive outcomes, the WCST,
showed a significant association with increased time in structured activities at 12 weeks
(estimated standardised regression coefficient &#x02212;0.28, 95% CI from &#x02212;0.51 to &#x02212;0.06).
Approximately 20% of the increase in (ln-)structured time in the CIRCuiTS arm was mediated
by a reduction in WCST errors. <table-wrap id="tab03" orientation="portrait" position="float"><label>Table 3.</label><caption><p>Mediation of CR effects on time spend in structured activities at 12 weeks by
primary cognitive outcomes (n&#x000a0;=&#x000a0;87)</p></caption><alternatives><graphic xlink:href="S0033291717001234_tab3"/><table frame="hsides" rules="groups"><col align="left" width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><col align="char" char="." width="1*" span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">Putative mediator</th><th align="left" rowspan="1" colspan="1">Estimated total effect of CR on
functioning (TAU-CR) [95% CI]<xref ref-type="table-fn" rid="tfn3_1">
<sup>a</sup>
</xref></th><th align="left" rowspan="1" colspan="1">Estimated effect of CR on mediator
(TAU-CR) [95% CI]</th><th align="left" rowspan="1" colspan="1">Estimated effect of mediator on
functioning (per baseline <sc>s.d.</sc>) [95% CI]</th><th align="left" rowspan="1" colspan="1">Direct (non-mediated) effect of CR on
functioning (TAU-CR) [95% CI]<xref ref-type="table-fn" rid="tfn3_1">
<sup>a</sup>
</xref></th><th align="left" rowspan="1" colspan="1">Indirect (mediated) effect of CR on
functioning (TAU-CR)&#x000a0; [95% CI]<xref ref-type="table-fn" rid="tfn3_2">
<sup>b</sup>
</xref> (<italic>p</italic> value)<xref ref-type="table-fn" rid="tfn3_3">
<sup>c</sup>
</xref></th><th align="left" rowspan="1" colspan="1">% mediated</th></tr></thead><tbody><tr><td rowspan="1" colspan="1">Verbal working memory (Digit span)</td><td rowspan="1" colspan="1">&#x02212;0.58 [&#x02212;0.96 to &#x02212;0.21]</td><td rowspan="1" colspan="1">&#x02212;0.18 [&#x02212;0.44 to 0.09]</td><td rowspan="1" colspan="1">&#x02212;0.11 [&#x02212;0.43 to 0.20]</td><td rowspan="1" colspan="1">&#x02212;0.60 [&#x02212;0.98 to &#x02212;0.23]</td><td rowspan="1" colspan="1">0.02 [&#x02212;0.05 to 0.10] (<italic>p</italic>&#x000a0;=&#x000a0;0.53)</td><td rowspan="1" colspan="1">n.a.<xref ref-type="table-fn" rid="tfn3_4">
<sup>d</sup>
</xref></td></tr><tr><td rowspan="1" colspan="1">Visual memory (ROCF)</td><td rowspan="1" colspan="1">&#x02212;0.58 [&#x02212;0.95 to &#x02212;0.21]</td><td rowspan="1" colspan="1">&#x02212;0.35 [&#x02212;0.61 to &#x02212;0.10]</td><td rowspan="1" colspan="1">&#x02212;0.05 [&#x02212;0.38 to 0.28]</td><td rowspan="1" colspan="1">&#x02212;0.60 [&#x02212;0.99 to &#x02212;0.21]</td><td rowspan="1" colspan="1">0.02 [&#x02212;0.08 to 0.19] (<italic>p</italic>&#x000a0;=&#x000a0;0.76)</td><td rowspan="1" colspan="1">n.a.<xref ref-type="table-fn" rid="tfn3_4">
<sup>d</sup>
</xref></td></tr><tr><td rowspan="1" colspan="1">Verbal executive function (Hayling)</td><td rowspan="1" colspan="1">&#x02212;0.57 [&#x02212;0.94 to &#x02212;0.17]</td><td rowspan="1" colspan="1">&#x02212;0.08 [&#x02212;0.39 to 0.23]</td><td rowspan="1" colspan="1">0.16 [&#x02212;0.11 to 0.43]</td><td rowspan="1" colspan="1">&#x02212;0.56 [&#x02212;0.93 to &#x02212;0.18]</td><td rowspan="1" colspan="1">&#x02212;0.01 [&#x02212;0.16 to 0.02] (<italic>p</italic>&#x000a0;=&#x000a0;0.64)</td><td rowspan="1" colspan="1">2.3%</td></tr><tr><td rowspan="1" colspan="1">Visual executive function (WCST)</td><td rowspan="1" colspan="1">&#x02212;0.53 [&#x02212;0.91 to &#x02212;0.15]</td><td rowspan="1" colspan="1">0.37 [&#x02212;0.01 to 0.75]</td><td rowspan="1" colspan="1">&#x02212;0.28 [&#x02212;0.51 to &#x02212;0.06]</td><td rowspan="1" colspan="1">&#x02212;0.43 [&#x02212;0.80 to &#x02212;0.05]</td><td rowspan="1" colspan="1">&#x02212;0.11 [&#x02212;0.31 to &#x02212;0.01] (<italic>p</italic>&#x000a0;=&#x000a0;0.12)</td><td rowspan="1" colspan="1">19.8%</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="tfn3_1"><label>a</label><p>Time spend in structured activities was ln-transformed and then standardised to
express functioning in units of baseline standard deviations (<sc>s.d.</sc>s).</p></fn><fn id="tfn3_2"><label>b</label><p>Confidence interval for direct effect is bias corrected bootstrap interval (using
1000 bootstrap replicates) as recommended in (MacKinnon &#x00026; Valente, <xref rid="ref18" ref-type="bibr">2014</xref>).</p></fn><fn id="tfn3_3"><label>c</label><p>Sobel test for zero mediation.</p></fn><fn id="tfn3_4"><label>d</label><p>Not applicable when the direct and indirect CR effect point in different
directions.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="discussion" id="sec4"><title>Discussion</title><sec id="sec4-1"><title>CIRCuITS feasibility</title><p>This study demonstrates that CIRCuiTS, a new generation computerised metacognitive CR
programme, is feasible for people with a schizophrenia diagnosis with cognitive
impairment. 85% of participants offered CIRCuiTS attended at least 20 sessions within 12
weeks. This adherence rate compares favourably with other CR studies (Wykes <italic>et al.</italic>
<xref rid="ref36" ref-type="bibr">2011</xref>), including computerised CR (Murthy
<italic>et al.</italic>
<xref rid="ref20" ref-type="bibr">2012</xref>). Six of the seven participants with poor
adherence stopped attending after only one or two sessions, suggesting that for most
participants engagement was achieved very quickly.</p><p>The target dose was 40 sessions but the median number for completers was 28. The average
attendance of approximately two sessions per week is consistent with attendance rates in
our previous trials, which have generally used extended time periods to achieve a higher
dose (Wykes <italic>et al.</italic>
<xref rid="ref39" ref-type="bibr">2007</xref>). One meta-analysis of CR (McGurk <italic>et
al.</italic>
<xref rid="ref19" ref-type="bibr">2007</xref>) reported a mean intensity of 2&#x000a0;hours per
week, and this remains a common regime in CR trials (Bowie <italic>et al.</italic>
<xref rid="ref2" ref-type="bibr">2012</xref>; Drake <italic>et al.</italic>
<xref rid="ref8" ref-type="bibr">2014</xref>). The persistence of a two session per week
norm, despite the emphasis on massed practice in CR programmes, may reflect the clinical
reality that motivating people with schizophrenia [known to often have motivational
impairments (Cella <italic>et al.</italic>
<xref rid="ref4" ref-type="bibr">2014</xref>)], to attend more than twice a week is
challenging.</p></sec><sec id="sec4-2"><title>Does CIRCuiTS lead to improved cognitive and functional outcomes?</title><p>Both post-therapy and at 3 month follow-up the CIRCuiTS group showed significantly
greater improvement in immediate visual memory. This is encouraging in light of findings
of deterioration in visual-spatial/constructional skills over 3 years in a sample of
people with chronic schizophrenia (Dickerson <italic>et al.</italic>
<xref rid="ref7" ref-type="bibr">2014</xref>): CIRCuiTS may protect against cognitive
decline. There was also a trend (<italic>p</italic>&#x000a0;=&#x000a0;0.056) for greater improvement in
WCST scores following CIRCuiTS, which may be important since this was the main cognitive
driver of functioning improvement.</p><p>Changes in other cognitive outcomes were not significantly different between groups. We
have noted that the mean number of sessions was lower than intended and consequently may
have been insufficient for consistent cognitive improvements. In fact, greater WCST and
social functioning improvements at post-treatment were associated with doing more therapy
sessions. The main theoretical change mechanism for CIRCuiTS, in addition to massed
practice, is via the development of metacognitive knowledge and metacognitive regulation,
including the use of strategies for a more systematic and organised approach to tasks.
Greater improvement in immediate visual memory was predicted by a higher mean number of
tasks carried out within sessions and a higher mean number of strategies rated as helpful
by patients. This is consistent with massed practice and strategy use being the chief
mechanisms of cognitive change. However, note that our study only estimates associations
with aspects of therapy, which are not necessarily causal.</p><p>A more strategic approach is likely to entail a considerable shift in the way in which
tasks are undertaken, and this may lead to an initial deterioration in performance (Harvey
<italic>et al.</italic>
<xref rid="ref13" ref-type="bibr">2009</xref>). The two cognitive tasks, which did not
show improvement require immediate, rapid responses, and so would not have been likely to
benefit from an increase in strategic thinking, which may take more time. However, better
strategy use does appear to underpin more efficient executive and memory performance in
schizophrenia in both the WCST (Choi &#x00026; Kurtz, <xref rid="ref5" ref-type="bibr">2009</xref>) and the ROCF (Landgraf <italic>et al.</italic>
<xref rid="ref17" ref-type="bibr">2011</xref>), consistent with the cognitive improvements
in this study.</p><p>To assess functional changes, we used a Time Use Survey measure in an attempt to capture
the wide range of changes (from gaining paid employment to beginning to meet with a
relative once or twice a week) that may be meaningful within a sample of people with a
schizophrenia diagnosis. CIRCuiTS led to improved community functioning post-therapy by
increasing the hours spent in structured activity, although this was not sustained at
follow-up. This presumably reflects the constraints of offering therapy within a research
context. For many people, sustained improvement and recovery requires maintained support.
This is consistent with findings that CR is most beneficial when offered in the context of
an adjunctive rehabilitation programme (Wykes <italic>et al.</italic>
<xref rid="ref36" ref-type="bibr">2011</xref>).</p></sec><sec id="sec4-3"><title>Does cognition mediate improvements in functioning?</title><p>Only improved executive functioning was associated with benefits for functioning: this
finding is well-supported in the literature (Reeder <italic>et al.</italic>
<xref rid="ref24" ref-type="bibr">2006</xref>, <xref rid="ref22" ref-type="bibr">2014</xref>; Eack <italic>et al.</italic>
<xref rid="ref9" ref-type="bibr">2009</xref>; Wykes <italic>et al.</italic>
<xref rid="ref38" ref-type="bibr">2012</xref>) and is consistent with the metacognitive
model, which underpins CIRCuiTS (Wykes &#x00026; Reeder, <xref rid="ref37" ref-type="bibr">2005</xref>). Executive functions are likely to be important CR targets to achieve
functional change. However, note that we cannot establish causality at this stage. Our
mediation models were exploratory in nature and make a number of assumptions; including
that there are no further hidden confounders of the cognition-functioning relationship and
that measurement error in cognitive variables is negligible.</p></sec><sec id="sec4-4"><title>Study limitations</title><p>Despite being one of the largest CR trials to date, our final sample size might have been
too low to identify moderate effects at the 5% significance level taking into account our
multiple outcome comparisons. Consequently, we may have failed to detect some effects of
CIRCuiTS.</p><p>We did not include an active control condition: a lack of agreement regarding what
constitutes specific <italic>v</italic>. non-specific effects of CR, combined with
evidence that active computerised CR controls may not be effective (Gomar <italic>et al.</italic>
<xref rid="ref11" ref-type="bibr">2015</xref>), made it difficult to justify public
funding support for an additional control treatment arm.</p></sec><sec id="sec4-5" sec-type="conclusion"><title>Conclusions</title><p>CIRCuiTS, a new generation computerised CR programme, is feasible to deliver both with
therapist-led and independent sessions. It led to improved performance in immediate visual
memory which relies on executive organisational skills for effective encoding, and this
improvement was maintained at 3-month follow-up. It also resulted in increased structured
activity post-therapy. A large-scale effectiveness trial is warranted.</p></sec></sec></body><back><ack id="ack"><title>Acknowledgements</title><p>Professor Til Wykes and Dr Clare Reeder jointly own the IP for CIRCuiTS along with King's
College London. CIRCuiTS therapists were Fiona Ram, Diane Agoro, India Webb, Natalia
Ghirasim, Dimitrios Kontis and Polly Crawford. The assessments were conducted by Sasha
Whaley, Evelina Medin, Sarah Swan, Gareth Drake, Nina Grant, Mary Jo Doyle and Clementine
Edwards. This work was supported by a Research for Patient Benefit grant from the National
Institute of Health Research, UK (grant reference number: PB-PG-0807-14002). Sabine Landau
and Til Wykes receive salary support from the National Institute for Health Research (NIHR)
(Mental Health Biomedical Research Centre) at the South London and Maudsley NHS Foundation
Trust and King's College London. Til Wykes also receives support from her NIHR Senior
Investigator award. The views expressed are those of the authors and not necessarily those
of the NHS, the NIHR or the Department of Health.</p><p><italic>Trial Registration:</italic> ISRCTN55488371 (<uri xlink:type="simple" xlink:href="http://www.isrctn.com/ISRCTN55488371">http://www.isrctn.com/ISRCTN55488371</uri>).</p></ack><sec sec-type="supplementary-material" id="sec5"><title>Supplementary material</title><supplementary-material content-type="local-data" id="S0033291717001234sup001"><p>For supplementary material accompanying this paper visit http://dx.doi.org/10.1017/S0033291717001234.</p><media xlink:href="S0033291717001234sup001.doc" mimetype="application" mime-subtype="msword" orientation="portrait" id="d35e1829" position="anchor"><caption><p>click here to view supplementary material</p></caption></media></supplementary-material></sec><notes notes-type="other" id="nts2"><title>Declaration of Interest</title><p>Professor Til Wykes and Dr Clare Reeder jointly own the IP for CIRCuiTS along with King's
College London.</p></notes><notes notes-type="other" id="nts3"><title>Ethical standards</title><p>The authors assert that all procedures contributing to this work comply with the ethical
standards of the relevant national and institutional committees on human experimentation and
with the Helsinki Declaration of 1975, as revised in 2008.</p></notes><ref-list id="reflist1"><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><name><surname>Baron</surname><given-names>RM</given-names></name>, <name><surname>Kenny</surname><given-names>DA</given-names></name> (<year>1986</year>). <article-title>The moderator mediator variable distinction in
social psychological-research &#x02013; Conceptual, strategic, and statistical
considerations</article-title>. <source>Journal of Personality and Social Psychology</source>
<volume>51</volume>, <fpage>1173</fpage>&#x02013;<lpage>1182</lpage>.<pub-id pub-id-type="pmid">3806354</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><name><surname>Bowie</surname><given-names>CR</given-names></name>, <name><surname>McGurk</surname><given-names>SR</given-names></name>, <name><surname>Mausbach</surname><given-names>B</given-names></name>, <name><surname>Patterson</surname><given-names>TL</given-names></name>, <name><surname>Harvey</surname><given-names>PD</given-names></name> (<year>2012</year>). <article-title>Combined cognitive remediation and functional
skills training for schizophrenia: effects on cognition, functional competence, and
real-world behavior</article-title>. <source>American Journal of Psychiatry</source>
<volume>169</volume>, <fpage>710</fpage>&#x02013;<lpage>718</lpage>.<pub-id pub-id-type="pmid">22581070</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="book"><name><surname>Burgess</surname><given-names>P</given-names></name>, <name><surname>Shallice</surname><given-names>T</given-names></name> (<year>1997</year>). <source>The Hayling and Brixton Tests</source>.
<publisher-name>Thames Valley Test Company/Pearson Assessment</publisher-name>:
<publisher-loc>Bury St. Edmunds, UK</publisher-loc>.</mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><name><surname>Cella</surname><given-names>M</given-names></name>, <name><surname>Bishara</surname><given-names>AJ</given-names></name>, <name><surname>Medin</surname><given-names>E</given-names></name>, <name><surname>Swan</surname><given-names>S</given-names></name>, <name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name> (<year>2014</year>). <article-title>Identifying cognitive remediation change
through computational modelling &#x02013; effects on reinforcement learning in
schizophrenia</article-title>. <source>Schizophrenia Bulletin</source>
<volume>40</volume>, <fpage>1422</fpage>&#x02013;<lpage>1432</lpage>.<pub-id pub-id-type="pmid">24214932</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><name><surname>Choi</surname><given-names>J</given-names></name>, <name><surname>Kurtz</surname><given-names>MM</given-names></name> (<year>2009</year>). <article-title>A comparison of remediation techniques on the
Wisconsin Card Sorting Test in schizophrenia</article-title>. <source>Schizophrenia
Research</source>
<volume>107</volume>, <fpage>76</fpage>&#x02013;<lpage>82</lpage>.<pub-id pub-id-type="pmid">18930632</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="book"><collab>CREW</collab> (<year>2012</year>).
<source>Definition of Cognitive Remediation</source>. <publisher-name>Cognitive
Remediation Expert Working Group</publisher-name>: <publisher-loc>Florence,
Italy</publisher-loc>.</mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal"><name><surname>Dickerson</surname><given-names>F</given-names></name>, <name><surname>Schroeder</surname><given-names>J</given-names></name>, <name><surname>Stallings</surname><given-names>C</given-names></name>, <name><surname>Origoni</surname><given-names>A</given-names></name>, <name><surname>Katsafanas</surname><given-names>E</given-names></name>, <name><surname>Schwienfurth</surname><given-names>LAB</given-names></name>, <name><surname>Savage</surname><given-names>CLG</given-names></name>, <name><surname>Khushalani</surname><given-names>S</given-names></name>, <name><surname>Yolken</surname><given-names>R</given-names></name> (<year>2014</year>). <article-title>A longitudinal study of cognitive functioning
in schizophrenia: clinical and biological predictors</article-title>.
<source>Schizophrenia Research</source>
<volume>156</volume>, <fpage>248</fpage>&#x02013;<lpage>253</lpage>.<pub-id pub-id-type="pmid">24827555</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><name><surname>Drake</surname><given-names>RJ</given-names></name>, <name><surname>Day</surname><given-names>CJ</given-names></name>, <name><surname>Picucci</surname><given-names>R</given-names></name>, <name><surname>Warburton</surname><given-names>J</given-names></name>, <name><surname>Larkin</surname><given-names>W</given-names></name>, <name><surname>Husain</surname><given-names>N</given-names></name>, <name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Marshall</surname><given-names>M</given-names></name> (<year>2014</year>). <article-title>A naturalistic, randomized, controlled trial
combining cognitive remediation with cognitive-behavioural therapy after first-episode
non-affective psychosis</article-title>. <source>Psychological Medicine</source>
<volume>44</volume>, <fpage>1889</fpage>&#x02013;<lpage>1899</lpage>.<pub-id pub-id-type="pmid">24172842</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><name><surname>Eack</surname><given-names>SM</given-names></name>, <name><surname>Greenwald</surname><given-names>DP</given-names></name>, <name><surname>Hogarty</surname><given-names>SS</given-names></name>, <name><surname>Cooley</surname><given-names>SJ</given-names></name>, <name><surname>DiBarry</surname><given-names>AL</given-names></name>, <name><surname>Montrose</surname><given-names>DM</given-names></name>, <name><surname>Keshavan</surname><given-names>MS</given-names></name> (<year>2009</year>). <article-title>Cognitive enhancement therapy for early-course
schizophrenia: effects of a two-year randomized controlled trial</article-title>.
<source>Psychiatric Services</source>
<volume>60</volume>, <fpage>1468</fpage>&#x02013;<lpage>1476</lpage>.<pub-id pub-id-type="pmid">19880464</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><name><surname>Flavell</surname><given-names>JH</given-names></name> (<year>1979</year>). <article-title>Metacognition and cognitive monitoring: a new
area of cognitive -developmental inquiry</article-title>. <source>American Psychologist</source>
<volume>34</volume>, <fpage>906</fpage>&#x02013;<lpage>911</lpage>.</mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><name><surname>Gomar</surname><given-names>JJ</given-names></name>, <name><surname>Valls</surname><given-names>E</given-names></name>, <name><surname>Radua</surname><given-names>J</given-names></name>, <name><surname>Mareca</surname><given-names>C</given-names></name>, <name><surname>Tristany</surname><given-names>J</given-names></name>, <name><surname>Del Olmo</surname><given-names>F</given-names></name>, <name><surname>Rebolleda-Gil</surname><given-names>C</given-names></name>, <name><surname>Janez-Alvarez</surname><given-names>M</given-names></name>, <name><surname>de Alvaro</surname><given-names>FJ</given-names></name>, <name><surname>Ovejero</surname><given-names>MR</given-names></name>, <name><surname>Llorente</surname><given-names>A</given-names></name>, <name><surname>Teixido</surname><given-names>C</given-names></name>, <name><surname>Donaire</surname><given-names>AM</given-names></name>, <name><surname>Garcia-Laredo</surname><given-names>E</given-names></name>, <name><surname>Lazcanoiturburu</surname><given-names>A</given-names></name>, <name><surname>Granell</surname><given-names>L</given-names></name>, <name><surname>Mozo</surname><given-names>CP</given-names></name>, <name><surname>Perez-Hernandez</surname><given-names>M</given-names></name>, <name><surname>Moreno-Alcazar</surname><given-names>A</given-names></name>, <name><surname>Pomarol-Clotet</surname><given-names>E</given-names></name>, <name><surname>McKenna</surname><given-names>PJ</given-names></name>, <collab>Cognitive Rehabilitation Study G</collab> (<year>2015</year>).
<article-title>A multisite, randomized controlled clinical trial of computerized
cognitive remediation therapy for schizophrenia</article-title>. <source>Schizophrenia
Bulletin</source>
<volume>41</volume>, <fpage>1387</fpage>&#x02013;<lpage>1396</lpage>.<pub-id pub-id-type="pmid">26006264</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><name><surname>Green</surname><given-names>MF</given-names></name>, <name><surname>Kern</surname><given-names>RS</given-names></name>, <name><surname>Braff</surname><given-names>DL</given-names></name>, <name><surname>Mintz</surname><given-names>J</given-names></name> (<year>2000</year>). <article-title>Neurocognitive deficits and functional outcome
in schizophrenia: are we measuring the &#x02018;right stuff&#x02019;?</article-title>
<source>Schizophrenia Bulletin</source>
<volume>26</volume>, <fpage>119</fpage>&#x02013;<lpage>136</lpage>.<pub-id pub-id-type="pmid">10755673</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><name><surname>Harvey</surname><given-names>KE</given-names></name>, <name><surname>Galletly</surname><given-names>CA</given-names></name>, <name><surname>Field</surname><given-names>C</given-names></name>, <name><surname>Proeve</surname><given-names>M</given-names></name> (<year>2009</year>). <article-title>The effects of verbalisation on cognitive
performance in schizophrenia: a pilot study using tasks from the Delis Kaplan Executive
Function System</article-title>. <source>Neuropsychological Rehabilitation</source>
<volume>19</volume>, <fpage>733</fpage>&#x02013;<lpage>741</lpage>.<pub-id pub-id-type="pmid">19255911</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="book"><name><surname>Heaton</surname><given-names>R</given-names></name>, <name><surname>Chelune</surname><given-names>G</given-names></name>, <name><surname>Talley</surname><given-names>J</given-names></name>, <name><surname>Kay</surname><given-names>G</given-names></name>, <name><surname>Curtiss</surname><given-names>G</given-names></name> (<year>1993</year>). <source>Wisconsin Card Sorting Test Manual, Revised and
Expanded</source>. <publisher-name>P. Resources</publisher-name>:
<publisher-loc>Odessa</publisher-loc>.</mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><name><surname>Kay</surname><given-names>SR</given-names></name>, <name><surname>Fiszbein</surname><given-names>A</given-names></name>, <name><surname>Opler</surname><given-names>LA</given-names></name> (<year>1987</year>). <article-title>The positive and negative syndrome scale
(panss) for schizophrenia</article-title>. <source>Schizophrenia Bulletin</source>
<volume>13</volume>, <fpage>261</fpage>&#x02013;<lpage>276</lpage>.<pub-id pub-id-type="pmid">3616518</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><name><surname>Krabbendam</surname><given-names>L</given-names></name>, <name><surname>Aleman</surname><given-names>A</given-names></name> (<year>2003</year>). <article-title>Cognitive rehabilitation in schizophrenia: a
quantitative analysis of controlled studies</article-title>. <source>Psychopharmacology</source>
<volume>169</volume>, <fpage>376</fpage>&#x02013;<lpage>382</lpage>.<pub-id pub-id-type="pmid">12545330</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><name><surname>Landgraf</surname><given-names>S</given-names></name>, <name><surname>Amado</surname><given-names>I</given-names></name>, <name><surname>Brucks</surname><given-names>M</given-names></name>, <name><surname>Krueger</surname><given-names>F</given-names></name>, <name><surname>Krebs</surname><given-names>M-O</given-names></name>, <name><surname>Van der Meer</surname><given-names>E</given-names></name> (<year>2011</year>). <article-title>Inflexible information acquisition strategies
mediate visuo-spatial reasoning in stabilized schizophrenia patients</article-title>.
<source>World Journal of Biological Psychiatry</source>
<volume>12</volume>, <fpage>608</fpage>&#x02013;<lpage>619</lpage>.<pub-id pub-id-type="pmid">21288070</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><name><surname>MacKinnon</surname><given-names>DP</given-names></name>, <name><surname>Valente</surname><given-names>MJ</given-names></name> (<year>2014</year>). <article-title>Mediation from multilevel to structural
equation modeling</article-title>. <source>Annals of Nutrition and Metabolism</source>
<volume>65</volume>, <fpage>198</fpage>&#x02013;<lpage>204</lpage>.<pub-id pub-id-type="pmid">25413658</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><name><surname>McGurk</surname><given-names>SR</given-names></name>, <name><surname>Twamley</surname><given-names>EW</given-names></name>, <name><surname>Sitzer</surname><given-names>DI</given-names></name>, <name><surname>McHugo</surname><given-names>GJ</given-names></name>, <name><surname>Mueser</surname><given-names>KT</given-names></name> (<year>2007</year>). <article-title>A meta-analysis of cognitive remediation in
schizophrenia</article-title>. <source>American Journal of Psychiatry</source>
<volume>164</volume>, <fpage>1791</fpage>&#x02013;<lpage>1802</lpage>.<pub-id pub-id-type="pmid">18056233</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><name><surname>Murthy</surname><given-names>NV</given-names></name>, <name><surname>Mahncke</surname><given-names>H</given-names></name>, <name><surname>Wexler</surname><given-names>BE</given-names></name>, <name><surname>Maruff</surname><given-names>P</given-names></name>, <name><surname>Inamdar</surname><given-names>A</given-names></name>, <name><surname>Zucchetto</surname><given-names>M</given-names></name>, <name><surname>Lund</surname><given-names>J</given-names></name>, <name><surname>Shabbir</surname><given-names>S</given-names></name>, <name><surname>Shergill</surname><given-names>S</given-names></name>, <name><surname>Keshavan</surname><given-names>M</given-names></name>, <name><surname>Kapur</surname><given-names>S</given-names></name>, <name><surname>Laruelle</surname><given-names>M</given-names></name>, <name><surname>Alexander</surname><given-names>R</given-names></name> (<year>2012</year>). <article-title>Computerized cognitive remediation training
for schizophrenia: an open label, multi-site, multinational methodology
study</article-title>. <source>Schizophrenia Research</source>
<volume>139</volume>, <fpage>87</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="pmid">22342330</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><name><surname>Osterreith</surname><given-names>PA</given-names></name> (<year>1944</year>). <article-title>Filetest de copie d'une figure complex:
contribution a l'etude de la perception et de la memoire</article-title>.
<source>Archives de Psychologie</source>
<volume>30</volume>, <fpage>286</fpage>&#x02013;<lpage>356</lpage>.</mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Harris</surname><given-names>V</given-names></name>, <name><surname>Pickles</surname><given-names>A</given-names></name>, <name><surname>Patel</surname><given-names>A</given-names></name>, <name><surname>Cella</surname><given-names>M</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name> (<year>2014</year>). <article-title>Does change in cognitive function predict
change in costs of care for people with a schizophrenia diagnosis following cognitive
remediation therapy?</article-title>
<source>Schizophrenia Bulletin</source>
<volume>40</volume>, <fpage>1472</fpage>&#x02013;<lpage>1481</lpage>.<pub-id pub-id-type="pmid">24682210</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Pile</surname><given-names>V</given-names></name>, <name><surname>Watson</surname><given-names>A</given-names></name>, <name><surname>Crawford</surname><given-names>P</given-names></name>, <name><surname>Huddy</surname><given-names>V</given-names></name>, <name><surname>Cella</surname><given-names>M</given-names></name>, <name><surname>Rose</surname><given-names>D</given-names></name>, <name><surname>Callard</surname><given-names>F</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name> (<year>2015</year>). <article-title>The feasibility and acceptability to service
users of CIRCuiTS &#x02013; computerised interactive remediation of cognition &#x02013; a training for
schizophrenia</article-title>. <source>Behavioural and Cognitive Psychotherapy Bulletin</source>
<volume>44</volume>, <fpage>288</fpage>&#x02013;<lpage>305</lpage>.</mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Smedley</surname><given-names>N</given-names></name>, <name><surname>Butt</surname><given-names>K</given-names></name>, <name><surname>Bogner</surname><given-names>D</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name> (<year>2006</year>). <article-title>Cognitive predictors of social functioning
improvements following cognitive remediation for schizophrenia</article-title>.
<source>Schizophrenia Bulletin</source>
<volume>32</volume>, <fpage>S123</fpage>&#x02013;<lpage>S131</lpage>.<pub-id pub-id-type="pmid">16901950</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="book"><name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Wykes</surname><given-names>T</given-names></name> (<year>2010</year>). <source>Cognitive Interaction Remediation of Cognition &#x02013; a
Training for Schizophrenia (CIRCuiTS)</source>. <publisher-name>King's College
London</publisher-name>: <publisher-loc>UK</publisher-loc>.</mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><name><surname>Rey</surname><given-names>A</given-names></name> (<year>1941</year>). <article-title>L'examen psychologique dans les cas
d'encephalopathie traumatique (Les problems.)</article-title>. <source>Archives de
Psychologie</source>
<volume>28</volume>, <fpage>215</fpage>&#x02013;<lpage>285</lpage>.</mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="book"><name><surname>Short</surname><given-names>S</given-names></name> (<year>2006</year>). <source>Review of the UK 2000 Time Use Survey</source>.
<publisher-name>O. f. N. Statistics</publisher-name>: <publisher-loc>London,
UK</publisher-loc>.</mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="other"><collab>SIGN</collab> (<year>2013</year>). A
national clinical guideline: Health Care Improvement.</mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><name><surname>Silverstein</surname><given-names>A</given-names></name> (<year>1982</year>). <article-title>Two- and four-subtest short forms of the
Wechsler adult intelligence scale-revised</article-title>. <source>Journal of Consulting
and Clinical Psychology</source>
<volume>50</volume>, <fpage>415</fpage>&#x02013;<lpage>418</lpage>.</mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="book"><collab>New York State, Office of Mental
Health</collab> (<year>2010</year>). <source>Personalized Recovery Oriented Services
Regulations (Part 512)</source>. <publisher-loc>New York State,
USA</publisher-loc>.</mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="book"><name><surname>Stenmark</surname><given-names>R</given-names></name> (<year>2006</year>). <source>Cognitive Remediation Therapy Fidelity
Scale</source>. <publisher-name>University of Lund</publisher-name>:
<publisher-loc>Jonkoping, Sweden</publisher-loc>.</mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><name><surname>Vinogradov</surname><given-names>S</given-names></name>, <name><surname>Fisher</surname><given-names>M</given-names></name>, <name><surname>de Villers-Sidani</surname><given-names>E</given-names></name> (<year>2012</year>). <article-title>Cognitive training for impaired neural systems
in neuropsychiatric illness</article-title>. <source>Neuropsychopharmacology</source>
<volume>37</volume>, <fpage>43</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="pmid">22048465</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><name><surname>Wallwork</surname><given-names>RS</given-names></name>, <name><surname>Fortgang</surname><given-names>R</given-names></name>, <name><surname>Hashimoto</surname><given-names>R</given-names></name>, <name><surname>Weinberger</surname><given-names>DR</given-names></name>, <name><surname>Dickinson</surname><given-names>D</given-names></name> (<year>2012</year>). <article-title>Searching for a consensus five-factor model of
the Positive and Negative Syndrome Scale for schizophrenia</article-title>.
<source>Schizophrenia Research</source>
<volume>137</volume>, <fpage>246</fpage>&#x02013;<lpage>250</lpage>.<pub-id pub-id-type="pmid">22356801</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="book"><name><surname>Wechsler</surname><given-names>D</given-names></name> (<year>1993</year>). <source>Wechsler Adult Intelligence Scale &#x02013; 3rd edn.,
manual</source>. <publisher-name>Psychological Corporation</publisher-name>:
<publisher-loc>San Antonio</publisher-loc>.</mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="book"><name><surname>Wechsler</surname><given-names>D</given-names></name> (<year>2001</year>). <source>Wechsler Test of Adult Reading
(<italic>WTAR</italic>)</source>. <publisher-name>The Psychological
Corporation</publisher-name>: <publisher-loc>San Antonio</publisher-loc>.</mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal"><name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Huddy</surname><given-names>V</given-names></name>, <name><surname>Cellard</surname><given-names>C</given-names></name>, <name><surname>McGurk</surname><given-names>SR</given-names></name>, <name><surname>Czobor</surname><given-names>P</given-names></name> (<year>2011</year>). <article-title>A meta-analysis of cognitive remediation for
schizophrenia: methodology and effect sizes</article-title>. <source>American Journal of
Psychiatry</source>
<volume>168</volume>, <fpage>472</fpage>&#x02013;<lpage>485</lpage>.<pub-id pub-id-type="pmid">21406461</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="book"><name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Reeder</surname><given-names>C</given-names></name> (<year>2005</year>). <source>Cognitive Remediation Therapy for Schizophrenia:
Theory and Practice</source>. <publisher-name>Brunner Routledge</publisher-name>:
<publisher-loc>London, UK</publisher-loc>.</mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal"><name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Huddy</surname><given-names>V</given-names></name>, <name><surname>Taylor</surname><given-names>R</given-names></name>, <name><surname>Wood</surname><given-names>H</given-names></name>, <name><surname>Ghirasim</surname><given-names>N</given-names></name>, <name><surname>Kontis</surname><given-names>D</given-names></name>, <name><surname>Landau</surname><given-names>S</given-names></name> (<year>2012</year>). <article-title>Developing models of how cognitive
improvements change functioning: mediation, moderation and moderated
mediation</article-title>. <source>Schizophrenia Research</source>
<volume>138</volume>, <fpage>88</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">22503640</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal"><name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Reeder</surname><given-names>C</given-names></name>, <name><surname>Landau</surname><given-names>S</given-names></name>, <name><surname>Everitt</surname><given-names>B</given-names></name>, <name><surname>Knapp</surname><given-names>M</given-names></name>, <name><surname>Patel</surname><given-names>A</given-names></name>, <name><surname>Romeo</surname><given-names>R</given-names></name> (<year>2007</year>). <article-title>Cognitive remediation therapy in schizophrenia
&#x02013; Randomised controlled trial</article-title>. <source>British Journal of Psychiatry</source>
<volume>190</volume>, <fpage>421</fpage>&#x02013;<lpage>427</lpage>.<pub-id pub-id-type="pmid">17470957</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal"><name><surname>Wykes</surname><given-names>T</given-names></name>, <name><surname>Spaulding</surname><given-names>WD</given-names></name> (<year>2011</year>). <article-title>Thinking about the future cognitive
remediation therapy-what works and could we do better?</article-title>
<source>Schizophrenia Bulletin</source>
<volume>37</volume>, <fpage>S80</fpage>&#x02013;<lpage>S90</lpage>.<pub-id pub-id-type="pmid">21860051</pub-id></mixed-citation></ref></ref-list></back></article>